BIORA THERAPEUTICS INC: Diferență între versiuni
Admin (discuție | contribuții) (Pagină nouă: Pagina dedicata companiei BIORA THERAPEUTICS INC listata cu simbolurile US.BIOR, US.BIORc, US.PROG ==Descriere companie== Progenity, Inc. is (https://www.progenity.com/) a biotechnology company. The Company is engaged in developing and commercializing molecular testing products in the fields of women's health, gastrointestinal health and oral biotherapeutics. It applies multi-omics approach, combining genomics, epigenomics, proteomics, and metabolomics, to its molecular test...) |
(The LinkTitles extension automatically added links to existing pages (https://github.com/bovender/LinkTitles).) |
||
| Linia 2: | Linia 2: | ||
==Descriere companie== | ==Descriere companie== | ||
Progenity, Inc. is (https://www.progenity.com/) a biotechnology company. The Company is engaged in developing and commercializing molecular testing products in the fields of women's health, gastrointestinal health and oral biotherapeutics. It applies multi-omics approach, combining genomics, epigenomics, proteomics, and metabolomics, to its molecular testing products and to the development of a suite of investigational ingestible devices and drug/device combinations designed to provide precise diagnostic sampling and drug delivery solutions. The Company’s molecular tests are: Innatal Prenatal Screen, Preparent Carrier Test, Riscover Hereditary Cancer Test, and Resura Prenatal Test for Monogenic Disease. The Company is also developing its pipeline products, such as Preecludia pre-eclampsia rule-out test, Drug Delivery System (DDS) platform, and Oral Biopharmaceutical Delivery System (OBDS). It is also developing an ingestible capsule platform designed to help diagnose and treat gastrointestinal (GI) disorders. | Progenity, Inc. is (https://www.progenity.com/) a biotechnology company. The Company is engaged in developing and commercializing molecular testing products in the fields of women's health, gastrointestinal health and oral biotherapeutics. It applies multi-omics approach, combining genomics, epigenomics, proteomics, and metabolomics, to its molecular testing products and to the development of a suite of investigational ingestible devices and drug/device combinations designed to provide precise diagnostic sampling and drug delivery solutions. The Company’s molecular tests are: Innatal Prenatal Screen, Preparent Carrier [[Test]], Riscover Hereditary Cancer Test, and Resura Prenatal Test for Monogenic Disease. The Company is also developing its pipeline products, such as Preecludia pre-eclampsia rule-out test, Drug Delivery System (DDS) platform, and Oral Biopharmaceutical Delivery System (OBDS). It is also developing an ingestible capsule platform designed to help diagnose and treat gastrointestinal (GI) disorders. | ||
==Grafic actiuni companie== | ==Grafic actiuni companie== | ||
Versiunea curentă din 29 septembrie 2024 15:58
Pagina dedicata companiei BIORA THERAPEUTICS INC listata cu simbolurile US.BIOR, US.BIORc, US.PROG
Descriere companie[edit | ]
Progenity, Inc. is (https://www.progenity.com/) a biotechnology company. The Company is engaged in developing and commercializing molecular testing products in the fields of women's health, gastrointestinal health and oral biotherapeutics. It applies multi-omics approach, combining genomics, epigenomics, proteomics, and metabolomics, to its molecular testing products and to the development of a suite of investigational ingestible devices and drug/device combinations designed to provide precise diagnostic sampling and drug delivery solutions. The Company’s molecular tests are: Innatal Prenatal Screen, Preparent Carrier Test, Riscover Hereditary Cancer Test, and Resura Prenatal Test for Monogenic Disease. The Company is also developing its pipeline products, such as Preecludia pre-eclampsia rule-out test, Drug Delivery System (DDS) platform, and Oral Biopharmaceutical Delivery System (OBDS). It is also developing an ingestible capsule platform designed to help diagnose and treat gastrointestinal (GI) disorders.
Grafic actiuni companie[edit | ]